IL18 and breast carcinoma: Mesenchymal stem cells-expressing IL-18 inhibited the proliferation and metastasis of breast cancer cells by activating immunocytes and immune cytokines, downregulating the proliferation marker Ki-67 and suppressing tumor angiogenesis [201].